Literature DB >> 15084474

Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase.

Xiaochun Jin1, Nemat Morsy, John Winston, Pankaj J Pasricha, Kennon Garrett, Hamid I Akbarali.   

Abstract

The capsaicin receptor TRPV1 is a nonselective cation channel that is expressed in sensory neurons. In this study, we examined the role of the nonreceptor cellular tyrosine kinase c-Src kinase in the modulation of the rat TRPV1. Capsaicin-induced currents in identified colonic dorsal root ganglion neurons were blocked by the c-Src kinase inhibitor PP2 and enhanced by the tyrosine phosphatase inhibitor sodium orthovandate. PP2 also abolished currents in human embryonic kidney-293 cells transfected with rat TRPV1, whereas cotransfection of TRPV1 with v-Src resulted in fivefold increase in capsaicin-induced currents. In cells transfected with dominant-negative c-Src and TRPV1, capsaicin-induced currents were decreased by approximately fourfold. TRPV1 co-immunoprecipitated with Src kinase and was tyrosine phosphorylated. These studies demonstrate that TRPV1 is a potential target for cellular tyrosine kinase-dependent phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084474     DOI: 10.1152/ajpcell.00113.2004

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  40 in total

Review 1.  Ion channel remodeling in gastrointestinal inflammation.

Authors:  H I Akbarali; E G Hawkins; G R Ross; M Kang
Journal:  Neurogastroenterol Motil       Date:  2010-07-05       Impact factor: 3.598

2.  Signaling pathways that mediate nerve growth factor-induced increase in expression and release of calcitonin gene-related peptide from sensory neurons.

Authors:  K A Park; J C Fehrenbacher; E L Thompson; D B Duarte; C M Hingtgen; M R Vasko
Journal:  Neuroscience       Date:  2010-09-24       Impact factor: 3.590

3.  Differential modulation of agonist and antagonist structure activity relations for rat TRPV1 by cyclosporin A and other protein phosphatase inhibitors.

Authors:  Larry V Pearce; Attila Toth; HyungChul Ryu; Dong Wook Kang; Hyun-Kyung Choi; Mi-Kyoung Jin; Jeewoo Lee; Peter M Blumberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-08       Impact factor: 3.000

4.  Physiology and pharmacology of the vanilloid receptor.

Authors:  Angel Messeguer; Rosa Planells-Cases; Antonio Ferrer-Montiel
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

5.  Inflammatory and neuropathic cold allodynia are selectively mediated by the neurotrophic factor receptor GFRα3.

Authors:  Erika K Lippoldt; Serra Ongun; Geoffrey K Kusaka; David D McKemy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-05       Impact factor: 11.205

Review 6.  Sensory TRP channels: the key transducers of nociception and pain.

Authors:  Aaron D Mickle; Andrew J Shepherd; Durga P Mohapatra
Journal:  Prog Mol Biol Transl Sci       Date:  2015-02-12       Impact factor: 3.622

7.  Differential regulation of TRPV1 channels by H2O2: implications for diabetic microvascular dysfunction.

Authors:  Daniel J DelloStritto; Patrick J Connell; Gregory M Dick; Ibra S Fancher; Brittany Klarich; Joseph N Fahmy; Patrick T Kang; Yeong-Renn Chen; Derek S Damron; Charles K Thodeti; Ian N Bratz
Journal:  Basic Res Cardiol       Date:  2016-02-24       Impact factor: 17.165

8.  G protein-coupled receptor signaling via Src kinase induces endogenous human transient receptor potential vanilloid type 6 (TRPV6) channel activation.

Authors:  Jennifer Spehr; Lian Gelis; Markus Osterloh; Sonja Oberland; Hanns Hatt; Marc Spehr; Eva M Neuhaus
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

9.  Acid activation of Trpv1 leads to an up-regulation of calcitonin gene-related peptide expression in dorsal root ganglion neurons via the CaMK-CREB cascade: a potential mechanism of inflammatory pain.

Authors:  Masako Nakanishi; Kenji Hata; Tomotaka Nagayama; Teruhisa Sakurai; Toshihiko Nishisho; Hiroki Wakabayashi; Toru Hiraga; Shigeyuki Ebisu; Toshiyuki Yoneda
Journal:  Mol Biol Cell       Date:  2010-06-09       Impact factor: 4.138

10.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.